Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.

Tissue-type plasminogen activator (tPA) is a major activator of fibrinolysis, which also attenuates the pro-inflammatory activity of lipopolysaccharide (LPS) in bone marrow-derived macrophages (BMDMs) and in vivo in mice. The activity of tPA as an LPS response modifier is independent of its proteina...

Full description

Bibliographic Details
Main Authors: Lipsa Das, Pardis Azmoon, Michael A Banki, Elisabetta Mantuano, Steven L Gonias
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0224738
id doaj-dbae6326c2dd496aa07ae915b6be1442
record_format Article
spelling doaj-dbae6326c2dd496aa07ae915b6be14422021-03-04T11:21:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011411e022473810.1371/journal.pone.0224738Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.Lipsa DasPardis AzmoonMichael A BankiElisabetta MantuanoSteven L GoniasTissue-type plasminogen activator (tPA) is a major activator of fibrinolysis, which also attenuates the pro-inflammatory activity of lipopolysaccharide (LPS) in bone marrow-derived macrophages (BMDMs) and in vivo in mice. The activity of tPA as an LPS response modifier is independent of its proteinase activity and instead, dependent on the N-methyl-D-aspartate Receptor (NMDA-R), which is expressed by BMDMs. The major Toll-like receptor (TLR) for LPS is TLR4. Herein, we show that enzymatically-inactive (EI) tPA blocks the response of mouse BMDMs to selective TLR2 and TLR9 agonists, rapidly reversing IκBα phosphorylation and inhibiting expression of TNFα, CCL2, interleukin-1β, and interleukin-6. The activity of EI-tPA was replicated by activated α2-macroglobulin, which like EI-tPA, signals through an NMDA-R-dependent pathway. EI-tPA failed to inhibit cytokine expression by BMDMs in response to agonists that target the Pattern Recognition Receptors (PRRs), NOD1 and NOD2, providing evidence for specificity in the function of EI-tPA. Macrophages isolated from the peritoneal space (PMs), without adding eliciting agents, expressed decreased levels of cell-surface NMDA-R compared with BMDMs. These cells were unresponsive to EI-tPA in the presence of LPS. However, when PMs were treated with CSF-1, the abundance of cell-surface NMDA-R increased and the ability of EI-tPA to neutralize the response to LPS was established. We conclude that the anti-inflammatory activity of EI-tPA is selective for TLRs but not all PRRs. The ability of macrophages to respond to EI-tPA depends on the availability of cell surface NMDA-R, which may be macrophage differentiation-state dependent.https://doi.org/10.1371/journal.pone.0224738
collection DOAJ
language English
format Article
sources DOAJ
author Lipsa Das
Pardis Azmoon
Michael A Banki
Elisabetta Mantuano
Steven L Gonias
spellingShingle Lipsa Das
Pardis Azmoon
Michael A Banki
Elisabetta Mantuano
Steven L Gonias
Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
PLoS ONE
author_facet Lipsa Das
Pardis Azmoon
Michael A Banki
Elisabetta Mantuano
Steven L Gonias
author_sort Lipsa Das
title Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
title_short Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
title_full Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
title_fullStr Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
title_full_unstemmed Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
title_sort tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in csf-1-differentiated macrophages.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description Tissue-type plasminogen activator (tPA) is a major activator of fibrinolysis, which also attenuates the pro-inflammatory activity of lipopolysaccharide (LPS) in bone marrow-derived macrophages (BMDMs) and in vivo in mice. The activity of tPA as an LPS response modifier is independent of its proteinase activity and instead, dependent on the N-methyl-D-aspartate Receptor (NMDA-R), which is expressed by BMDMs. The major Toll-like receptor (TLR) for LPS is TLR4. Herein, we show that enzymatically-inactive (EI) tPA blocks the response of mouse BMDMs to selective TLR2 and TLR9 agonists, rapidly reversing IκBα phosphorylation and inhibiting expression of TNFα, CCL2, interleukin-1β, and interleukin-6. The activity of EI-tPA was replicated by activated α2-macroglobulin, which like EI-tPA, signals through an NMDA-R-dependent pathway. EI-tPA failed to inhibit cytokine expression by BMDMs in response to agonists that target the Pattern Recognition Receptors (PRRs), NOD1 and NOD2, providing evidence for specificity in the function of EI-tPA. Macrophages isolated from the peritoneal space (PMs), without adding eliciting agents, expressed decreased levels of cell-surface NMDA-R compared with BMDMs. These cells were unresponsive to EI-tPA in the presence of LPS. However, when PMs were treated with CSF-1, the abundance of cell-surface NMDA-R increased and the ability of EI-tPA to neutralize the response to LPS was established. We conclude that the anti-inflammatory activity of EI-tPA is selective for TLRs but not all PRRs. The ability of macrophages to respond to EI-tPA depends on the availability of cell surface NMDA-R, which may be macrophage differentiation-state dependent.
url https://doi.org/10.1371/journal.pone.0224738
work_keys_str_mv AT lipsadas tissuetypeplasminogenactivatorselectivelyinhibitsmultipletolllikereceptorsincsf1differentiatedmacrophages
AT pardisazmoon tissuetypeplasminogenactivatorselectivelyinhibitsmultipletolllikereceptorsincsf1differentiatedmacrophages
AT michaelabanki tissuetypeplasminogenactivatorselectivelyinhibitsmultipletolllikereceptorsincsf1differentiatedmacrophages
AT elisabettamantuano tissuetypeplasminogenactivatorselectivelyinhibitsmultipletolllikereceptorsincsf1differentiatedmacrophages
AT stevenlgonias tissuetypeplasminogenactivatorselectivelyinhibitsmultipletolllikereceptorsincsf1differentiatedmacrophages
_version_ 1714803852545359872